UZH Life Sciences Fund

Venture Capital Zurich, Switzerland ·Founded 2016

Overview

The UZH Life Sciences Fund (LSF), established in 2016, provides early financing for University of Zurich (UZH) spin-offs in life sciences, biotech, and medtech sectors. The fund focuses on business ideas based on intellectual property resulting from UZH research, aiming to accelerate the development process of spin-offs in their early stages, thereby facilitating the transfer of UZH research findings into practical applications that benefit patients and the public. The LSF is a partnership between the UZH Foundation and the Novartis Venture Fund (NVF), each contributing equal funding. Investment decisions are made by a committee comprising equal numbers of representatives from UZH and NVF. The fund primarily invests in seed and early-stage companies within Switzerland, focusing on sectors such as biotechnology, medtech, diagnostics, eHealth, and digital health. Since its inception, the LSF has supported nine spin-offs, which have collectively raised over 350 million CHF, created more than 100 jobs, and advanced several treatments into clinical trials. Notable portfolio companies include Cutiss, Anaveon, ImmunOS, EraCal, Occlufit, InCephalo, Navignostics, Fimmcyte, and metaLead. The fund aims to establish a capital base of 20 million CHF to further its mission of translating UZH research into clinical practice.

Investment Focus

  • Current or future spin-offs of the University of Zurich in life sciences (biotech, medtech, labtech, etc.)

Portfolio Companies

FimmCyteNavignosticsAnaveonInCephaloCUTISSImmunOSEraCalOcclufitmetaLead

Get the full list of 54,000+ investors

UZH Life Sciences Fund and every other firm and angel in the database — as one spreadsheet you keep.

$19one-time payment · no subscription
  • All 54,000+ investors — VC firms, private equity, family offices and angels
  • The key person to contact at each one, with their job title
  • Their work email address
  • Their phone number
  • Their LinkedIn profile
  • Delivered as a single .xlsx file — download it as many times as you like
Get the full list — $19 → One payment. No seats, no credits, no expiry. Already bought it? Sign in to download it again — no second payment.

Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.

Frequently asked questions about UZH Life Sciences Fund

What sectors does UZH Life Sciences Fund invest in?

UZH Life Sciences Fund invests in Digital Health, Medtech, Biotechnology, eHealth and Diagnostic, and is based in Zurich, Switzerland. UZH Life Sciences Fund is listed as a venture capital in the ConnectSafely investor database.

What stage does UZH Life Sciences Fund invest at?

UZH Life Sciences Fund backs companies at Seed and Early Stage, writing cheques of 1M - 1M.

Which regions does UZH Life Sciences Fund invest in?

UZH Life Sciences Fund invests across Switzerland.

What companies has UZH Life Sciences Fund invested in?

UZH Life Sciences Fund's portfolio includes FimmCyte, Navignostics, Anaveon, InCephalo, CUTISS, ImmunOS, EraCal and Occlufit.

Last updated · Source: ConnectSafely investor database